Results of an open-label, randomized, comparative clinical trial of nifuratel in the eradication of Helicobacter pylori infection in adult patients
Objective. To assess efficacy and safety of 14-day triple nifuratel-based therapy compared to 14-day standard triple therapy in adult patients with symptomatic H. pylori infection. Materials and Methods. A total of 70 patients with dyspepsia and microbiologically confirmed H. pylori infection we...
Main Authors: | Dekhnich N.N., Tryapyshko A.A., Trushin I.V., KuzmenkovA.Yu., Kozlov R.S. |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
2020-05-01
|
Series: | Клиническая микробиология и антимикробная химиотерапия |
Subjects: | |
Online Access: | https://cmac-journal.ru/publication/2020/2/cmac-2020-t22-n2-p119/cmac-2020-t22-n2-p119.pdf |
Similar Items
-
Helicobacter pylori eradication: Current aspects
by: V V Tsukanov, et al.
Published: (2013-02-01) -
Nifuratel Application in Therapy of Urinary Tract Infections
by: Ya.A. Dombrovskyi, et al.
Published: (2014-10-01) -
Local join therapy of vaginal infections by nifuratel-nistatin
by: Amra Habibović,, et al.
Published: (2010-02-01) -
Simvastatin improves the eradication rate of Helicobacter pylori: upper Egypt experience
by: Hassan AM, et al.
Published: (2019-06-01) -
Role of Helicobacter pylori eradication in the prevention of gastric cancer
by: V V Tsukanov, et al.
Published: (2014-08-01)